Approval · Notice of Compliance 30643 · 2023
IMCIVREE: Notice of Compliance 30643
Issued May 5, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30643
- Date
- May 5, 2023
- Company
- Rhythm Pharmaceuticals, IncBoston, Massachusetts, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IMCIVREE | 02537745 | Marketed |
Medicinal ingredients
- SETMELANOTIDE ACETATE 10 MG per ML